Last Updated: September 24, 2026

Perrigo Pharma Intl Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for PERRIGO PHARMA INTL

PERRIGO PHARMA INTL has nine approved drugs.

There is one tentative approval on PERRIGO PHARMA INTL drugs.

Summary for Perrigo Pharma Intl

US Patents:	0
Tradenames:	7
Ingredients:	7
NDAs:	9

Drugs and US Patents for Perrigo Pharma Intl

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Perrigo Pharma Intl	LORATADINE	loratadine	TABLET, ORALLY DISINTEGRATING;ORAL	076011-001	Sep 29, 2003		OTC	No	No		⤷ Start Trial				⤷ Start Trial
Perrigo Pharma Intl	LORATADINE AND PSEUDOEPHEDRINE SULFATE	loratadine; pseudoephedrine sulfate	TABLET, EXTENDED RELEASE;ORAL	076050-001	Jan 30, 2003		OTC	No	No		⤷ Start Trial				⤷ Start Trial
Perrigo Pharma Intl	PREVACID 24 HR	lansoprazole	CAPSULE, DELAYED REL PELLETS;ORAL	022327-001	May 18, 2009		OTC	Yes	Yes		⤷ Start Trial				⤷ Start Trial
Perrigo Pharma Intl	NASONEX 24HR ALLERGY	mometasone furoate	SPRAY, METERED;NASAL	215712-001	Mar 17, 2022		OTC	Yes	Yes		⤷ Start Trial				⤷ Start Trial
Perrigo Pharma Intl	DICLOFENAC SODIUM	diclofenac sodium	GEL;TOPICAL	211253-001	May 16, 2019		OTC	No	No		⤷ Start Trial				⤷ Start Trial
Perrigo Pharma Intl	TRIAMCINOLONE ACETONIDE	triamcinolone acetonide	SPRAY, METERED;NASAL	078104-002	Nov 14, 2014		OTC	No	No		⤷ Start Trial				⤷ Start Trial
Perrigo Pharma Intl	TRIAMCINOLONE ACETONIDE	triamcinolone acetonide	SPRAY, METERED;NASAL	078104-001	Jul 30, 2009		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.